Status:

COMPLETED

Oscillations in Reward-guided Behavior

Lead Sponsor:

Swiss Federal Institute of Technology

Conditions:

Reward-guided Behaviour

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

While people are reading, talking or playing computer games, their brain cells elicit electrical signals so they could perform these actions. The firing of these cells is not random but is organized i...

Eligibility Criteria

Inclusion

  • General Inclusion Criteria:
  • signed informed consent
  • Age 18-40 years
  • Normal physical and mental status (i.e. no neurological, musculoskeletal, neuromuscular, cognitive, or psychiatric disorders)
  • If a participant already took part in the experiment with the same decision-making task
  • Exclusion Criteria for TI electrical stimulation:
  • pregnancy
  • epilepsy
  • head traumas
  • implants (cochlear, neurostimulators, cardiac pacemakers, medication infusion device)
  • metal in the brain or skull
  • work in the metal industry
  • scars or inflammations on the regions, where the stimulation electrodes are placed
  • administration of antipsychotic or anti-epileptic medication
  • hearing problems or ringing in the ears
  • syncope or fainting spells in the last 5 years
  • severe side-effects after transcranial magnetic stimulation (TMS) or electrical stimulation if participant underwent it before
  • the inability to comply with magnetic resonance imaging (MRI) inclusion criteria if participant underwent it before
  • Exclusion Criteria for MRI experiments:
  • pregnancy
  • claustrophobia
  • history of brain surgery
  • family member that suffers from epilepsy
  • suffering from medication abuse for more than a year or drug intake
  • taking medications for medical reasons for more than a month
  • receiving of depot injections
  • one or more of the following materials in the body: metallic objects (e.g., dental implants, a metallic splinter in the eye, but not braces); wire, pacemaker or implanted defibrillator; artificial heart valves; vascular grafts; bio-stimulator or nerve stimulator; aneurysm or intracranial clip; cochlear implant; other prostheses or orthoses; implanted medication pump (insulin or pain pump); medicated patch (e.g., nitro-patch, pain patch, nicotine patch, hormone patch, motion sickness patch); other implants; tattoo or jewelry
  • history of any of these illnesses: brain thrombosis, stroke, traumatic brain injury, meningitis, heart attack, prolonged loss of consciousness, migraine, epilepsy

Exclusion

    Key Trial Info

    Start Date :

    February 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 4 2023

    Estimated Enrollment :

    70 Patients enrolled

    Trial Details

    Trial ID

    NCT04761471

    Start Date

    February 1 2021

    End Date

    December 4 2023

    Last Update

    December 13 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    ETH Zurich

    Zurich, Schweiz, Switzerland, 8057